These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8610807)

  • 1. Choroidal hemorrhage associated with systemic tissue plasminogen activator.
    Khawly JA; Ferrone PJ; Holck DE
    Am J Ophthalmol; 1996 May; 121(5):577-8. PubMed ID: 8610807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemorrhagic ocular complications associated with the use of systemic thrombolytic agents.
    Chorich LJ; Derick RJ; Chambers RB; Cahill KV; Quartetti EJ; Fry JA; Bush CA
    Ophthalmology; 1998 Mar; 105(3):428-31. PubMed ID: 9499772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous suprachoroidal hemorrhage secondary to thrombolysis for the treatment of myocardial infarction.
    Barsam A; Heatley CJ; Herbert L
    Clin Exp Ophthalmol; 2006 Mar; 34(2):177-9. PubMed ID: 16626438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal and Choroidal Haemorrhage after Tissue Plasminogen Activator Administration.
    Lee S; Gjerde H; Gubitz G
    Can J Neurol Sci; 2017 Jul; 44(4):461-462. PubMed ID: 28294935
    [No Abstract]   [Full Text] [Related]  

  • 5. Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid.
    Kamei M; Tano Y; Maeno T; Ikuno Y; Mitsuda H; Yuasa T
    Am J Ophthalmol; 1996 Mar; 121(3):267-75. PubMed ID: 8597269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anaphylactoid reaction during administration of tissue plasminogen activator (t-PA)].
    Cannas S; De Leo A; Marzari A
    G Ital Cardiol; 1997 Mar; 27(3):278-80. PubMed ID: 9244730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute suprachoroidal haemorrhage post-tenecteplase thrombolysis for myocardial infarction: management considerations.
    Trikha S; Lockwood A; Puvanachandra N; Kirwan J
    BMJ Case Rep; 2010 May; 2010():. PubMed ID: 22753301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal sensitivity after displacement of submacular hemorrhage due to polypoidal choroidal vasculopathy: effectiveness and safety of subretinal tissue plasminogen activator.
    Kimura S; Morizane Y; Matoba R; Hosokawa M; Shiode Y; Hirano M; Doi S; Toshima S; Takahashi K; Hosogi M; Fujiwara A; Shiraga F
    Jpn J Ophthalmol; 2017 Nov; 61(6):472-478. PubMed ID: 28836011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of submacular hemorrhage associated with idiopathic polypoidal choroidal vasculopathy.
    Shiraga F; Matsuo T; Yokoe S; Takasu I; Okanouchi T; Ohtsuki H; Grossniklaus HE
    Am J Ophthalmol; 1999 Aug; 128(2):147-54. PubMed ID: 10458169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid resorption of intraventricular hemorrhage after thrombolytic therapy of ischemic stroke.
    Szabo K; Sommer A; Gass A; Hennerici M
    Cerebrovasc Dis; 2001 Aug; 12(2):144. PubMed ID: 11490110
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravitreal injection of tissue plasminogen activator and gas bubble for treatment of subretinal hemorrhage in ARMD.
    Hay SR; Madonna RJ
    Optometry; 2000 Nov; 71(11):715-21. PubMed ID: 11101129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lingual haematoma after treatment with alteplase (recombinant tissue plasminogen activator) for acute myocardial infarction.
    McMechan SR; Morrow B; Campbell NP
    Br Heart J; 1995 Aug; 74(2):205. PubMed ID: 7547005
    [No Abstract]   [Full Text] [Related]  

  • 14. Tissue plasminogen activator in the surgical excision of subfoveal choroidal neovascular membranes.
    Thomas JW; Lopez PF; Lambert HM
    Ophthalmic Surg; 1995; 26(4):374-6. PubMed ID: 8532296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators.
    Bode C; Smalling RW; Berg G; Burnett C; Lorch G; Kalbfleisch JM; Chernoff R; Christie LG; Feldman RL; Seals AA; Weaver WD
    Circulation; 1996 Sep; 94(5):891-8. PubMed ID: 8790022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental Dullness after thrombolytic therapy.
    Woo KS; Chan HC; Poon WS
    Postgrad Med J; 1997 Jun; 73(860):347-9. PubMed ID: 9246336
    [No Abstract]   [Full Text] [Related]  

  • 17. Lingual haematoma after treatment with alteplase (recombinant tissue plasminogen activator) for acute myocardial infarction.
    Kounis NG; Zarras GM; Frangides C; Andreas A
    Heart; 1996 Apr; 75(4):427. PubMed ID: 8705778
    [No Abstract]   [Full Text] [Related]  

  • 18. Simultaneous bilateral thalamic hemorrhages following the administration of intravenous tissue plasminogen activator.
    Dromerick AW; Meschia JF; Kumar A; Hanlon RE
    Arch Phys Med Rehabil; 1997 Jan; 78(1):92-4. PubMed ID: 9014966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal tissue plasminogen activator in submacular haemorrhage.
    Singh P; Singh R; Kishore KS; Vig VK; Singh R; Singh B
    Indian J Ophthalmol; 1999 Dec; 47(4):254-5. PubMed ID: 10892486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemoptysis and unilateral intra-alveolar hemorrhage complicating intravenous thrombolysis for myocardial infarction.
    Hammoudeh AJ; Haft JI; Eichman GT
    Clin Cardiol; 1996 Jul; 19(7):595-6. PubMed ID: 8818443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.